From targeted therapy to a novel way: Immunogenic cell death in lung cancer

From targeted therapy to a novel way: Immunogenic cell death in lung cancer

Lung cancer (LC) is one of the most incident malignancies and a leading cause of cancer mortality worldwide. Common tumorigenic drivers of LC mainly include genetic alterations of EGFR, ALK, KRAS, BRAF, ROS1, and MET. Small inhibitory molecules and antibodies selectively targeting these alterations...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Jiawei Xu, Yiyi Xiong, Zhou Xu, Hongquan Xing, Lingyun Zhou, Xinyi Zhang
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2022-12-01
Cyfres:Frontiers in Medicine
Pynciau:
immunogenic cell death
lung cancer
immunotherapy
damage-associated molecular patterns
genetic alteration
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fmed.2022.1102550/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fmed.2022.1102550/full

Eitemau Tebyg